Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine as Adjuvant Therapy in Treatment-Resistant Schizophrenia
NCT00565175Phase 4Completed
- Start
- Jan 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of famotidine in schizophrenia. Started Jan 2008; status: completed.
02
Drugs
famotidine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00565175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565175.